NGK invests in medical cold plasma jet technology

1 September 2022  

NGK SPARK PLUG has entered into a strategic partnership with neoplas med GmbH, a German medical company that specialises in innovative cold plasma jet technology which helps in the treatment of wounds.

The collaboration will involve NGK investing growth capital from its Venture Capital Fund CVC, jointly operated with Pegasus Tech Ventures) into the medical company.
NGK has worked in the medical sector for many decades, where it has placed a particular emphasis on early disease detection, respiratory care and wound care.

Dirk Schapeler, President of Business Creation at NGK SPARK PLUG, said: “With our investment, we want to accompany the collaboration with neoplas med in the field of state-of-the-art wound healing technologies to improve the quality of life of patients worldwide. Our goal is to accompany the worldwide use and further development of this ground-breaking technology in the long term.”

Damien Germès, President & CEO of NGK SPARK PLUG EUROPE GmbH, Regional President EMEA and Corporate Officer of the Global Headquarters in Japan, added: “This strategic partnership with German neoplas med offers a snapshot of the transformation currently occurring at our company. Next to ‘Smart Mobility’ and ‘Utility’, ‘Smart Health’ is another one of the areas we are investing in as we continue on our mission to become an environmentally sustainable company that brings new value to the world.”

For more information, visit: www.ngkntk.com